Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.76 |
| ▸ | POLB | P06746 | 4/20 | 0.76 |
| ▸ | RAB9A | P51151 | 3/20 | 0.76 |
| ▸ | MEN1 | O00255 | 3/20 | 0.76 |
| ▸ | MAOB | P27338 | 2/20 | 0.73 |
| ▸ | MAOA | P21397 | 1/20 | 0.73 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.68 |
| ▸ | NPC1 | O15118 | 3/20 | 0.68 |
| ▸ | HPGD | P15428 | 2/20 | 0.68 |
| ▸ | LMNA | P02545 | 2/20 | 0.68 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.68 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.68 |
| ▸ | RELA | Q04206 | 1/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.68 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.68 |
| ▸ | PKM | P14618 | 3/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL979281 | 1.00 | MAPT (0.76) | MAPTKDM4EALDH1A1KMT2APOLB | |
| SCHEMBL11413572 | 1.00 | MAPT (0.76) | MAPTKDM4EALDH1A1KMT2APOLB | |
| SCHEMBL11701729 | 0.93 | MAPT (0.87) | MAPTKDM4EALDH1A1KMT2APOLB | |
| SCHEMBL11701738 | 0.93 | MAPT (0.87) | MAPTKDM4EALDH1A1KMT2APOLB | |
| SCHEMBL11474332 | 0.91 | MAPT (0.79) | MAPTKDM4EALDH1A1KMT2APOLB | |
| SCHEMBL11473225 | 0.91 | MAPT (0.79) | MAPTKDM4EALDH1A1KMT2APOLB | |
| SCHEMBL5597969 | 0.86 | MAPT (1.00) | MAPTKDM4EALDH1A1KMT2APOLB | |
| SCHEMBL10507733 | 0.86 | MAPT (1.00) | MAPTKDM4EALDH1A1KMT2APOLB | |
| SCHEMBL10944213 | 0.86 | MAPT (1.00) | MAPTKDM4EALDH1A1KMT2APOLB | |
| SCHEMBL14458244 | 0.86 | KMT2A (0.67) | MAPTKDM4EALDH1A1KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119192224-A | Alpha, beta-unsaturated ketone cyano silanization method and application | 哈尔滨理工大学 | 2024-12-27 | — | — | CN | claimed |
| CN-119192224-A | Alpha, beta-unsaturated ketone cyano silanization method and application | 哈尔滨理工大学 | 2024-12-27 | — | — | CN | disclosed |
| EP-2810198-B1 | ANTI-INVASIVE COMPOUNDS | UNIV GENT (BE) | 2023-07-12 | — | — | EP | disclosed |
| US-11661407-B2 | Process for the preparation of pyrylium salts | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2023-05-30 | — | — | US | disclosed |
| CN-108623425-B | Method for constructing four-membered ring by visible light catalysis [2+2] reaction | 中国科学院理化技术研究所 | 2021-05-14 | — | — | CN | disclosed |
| US-20210087158-A1 | A PROCESS FOR THE PREPARATION OF PYRYLIUM SALTS | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2021-03-25 | — | — | US | disclosed |
| US-10201879-B2 | Silver paste composition and semiconductor device using same | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2019-02-12 | — | — | US | disclosed |
| EP-2894641-B1 | SILVER PASTE COMPOSITION AND SEMICONDUCTOR DEVICE USING SAME | HITACHI CHEMICAL CO LTD (JP) | 2017-07-26 | — | — | EP | disclosed |
| US-20150217411-A1 | SILVER PASTE COMPOSITION AND SEMICONDUCTOR DEVICE USING SAME | RESONAC CORPORATION (JP) | 2015-08-06 | — | — | US | disclosed |
| EP-2894641-A1 | SILVER PASTE COMPOSITION AND SEMICONDUCTOR DEVICE USING SAME | Hitachi Chemical Company, Ltd. (JP) | 2015-07-15 | — | — | EP | disclosed |
| US-20070037752-A1 | Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases | KEYNEUROTEK PHARMACEUTICALS AG (DE) | 2007-02-15 | — | — | US | disclosed |
| US-20070037752-A1 | Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases | KEYNEUROTEK PHARMACEUTICALS AG (DE) | 2007-02-15 | — | — | US | disclosed |
| WO-2005037779-A2 | NOVEL DIPEPTIDYL PEPTIDASE IV INHIBITORS USED FOR FUNCTIONALLY INFLUENCING DIFFERENT CELLS AND TREATING IMMUNOLOGICAL, INFLAMMATORY, NEURONAL, AND OTHER DISEASES | IMTM GMBH (DE) | 2005-04-28 | — | — | WO | disclosed |
| WO-2005037257-A2 | NOVEL ALANYL-AMINO PEPTIDASE INHIBITORS FOR FUNCTIONALLY INFLUENCING DIFFERENT CELLS AND TREATING IMMUNOLOGICAL, INFLAMMATORY, NEURONAL, AND OTHER DISEASES | IMTM GMBH (DE) | 2005-04-28 | — | — | WO | disclosed |
| WO-2005034940-A2 | DUAL ALANYL AMINOPEPTIDASE AND DIPEPTIDYL PEPTIDASE IV INHIBITORS FOR FUNCTIONALLY INFLUENCING DIFFERENT CELLS AND FOR TREATING IMMUNOLOGICAL, INFLAMMATORY, NEURONAL AND OTHER DISEASES | IMTM GMBH (DE) | 2005-04-21 | — | — | WO | disclosed |
| EP-0662968-A1 | PHOTOCHROMIC NAPHTHOPYRAN COMPOUNDS | PPG INDUSTRIES, INC. (US) | 1995-07-19 | — | — | EP | disclosed |
| EP-0662968-A4 | PHOTOCHROMIC NAPHTHOPYRAN COMPOUNDS. | PPG INDUSTRIES INC (US) | 1995-04-12 | — | — | EP | disclosed |
| WO-1994007889-A1 | PHOTOCHROMIC NAPHTHOPYRAN COMPOUNDS | PPG INDUSTRIES, INC. (US) | 1994-04-14 | — | — | WO | disclosed |
| US-5274132-A | Photochromic naphthopyran compounds | TRANSITIONS OPTICAL, INC. (US) | 1993-12-28 | — | — | US | disclosed |
| US-5037824-A | Cardiotonic, antiischemic agents | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1991-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210087158-A1 | A PROCESS FOR THE PREPARATION OF PYRYLIUM SALTS | IPO5, SF3B5, CYP4F11 | MAPT 2365/4885KDM4E 1880/4885ALDH1A1 2811/4885 |
| US-20070037752-A1 | Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases | DNPEP, PREP, ANPEP | MAPT 1400/4885KDM4E 3461/4885ALDH1A1 1025/4885 |
| US-11661407-B2 | Process for the preparation of pyrylium salts | SF3B5, IPO5, CYP4F11 | MAPT 2455/4885KDM4E 1721/4885ALDH1A1 2917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.